Frequencies for measure_name variable in measure_dates dataset : Measure_Name | Freq. Percent Cum. ----------------------------------------+----------------------------------- 30-Day All-Cause Mortality Following .. | 1 0.62 0.62 30-Day All-Cause Unplanned Readmissio.. | 1 0.62 1.23 30-Day Hospital-Wide All-Cause Unplan.. | 1 0.62 1.85 30-Day Readmission Rate Following Ele.. | 1 0.62 2.47 ACS Participation data | 1 0.62 3.09 AHRQ_PSI_90_Score | 1 0.62 3.70 Abdomen CT - Use of Contrast Material | 1 0.62 4.32 Accidental puncture or laceration Rate | 1 0.62 4.94 Acute Ischemic Stroke (STK) 30-Day Mo.. | 1 0.62 5.56 Acute Myocardial Infarction (AMI) 30-.. | 3 1.85 7.41 Acute Myocardial Infarction (AMI) 30-.. | 1 0.62 8.02 Acute Myocardial Infarction (AMI) 30-.. | 1 0.62 8.64 Adjuvant Chemotherapy Colon Cancer | 1 0.62 9.26 Adjuvant Hormonal Therapy | 1 0.62 9.88 Admit Decision Time to ED Departure T.. | 1 0.62 10.49 Alcohol Use Screening | 1 0.62 11.11 Anticoagulation Therapy for Atrial Fi.. | 1 0.62 11.73 Antithrombotic Therapy By End of Hosp.. | 1 0.62 12.35 Appropriate Follow-up Interval for No.. | 1 0.62 12.96 Aspirin at Arrival | 1 0.62 13.58 Assessed for Rehabilitation | 1 0.62 14.20 Assessment of Patient Experience of C.. | 1 0.62 14.81 CAUTI_Score | 1 0.62 15.43 CLABSI_Score | 1 0.62 16.05 Cardiac imaging for preoperative risk.. | 1 0.62 16.67 Catheter Associated Urinary Tract Inf.. | 2 1.23 17.90 Catheter Associated Urinary Tract Inf.. | 1 0.62 18.52 Catheter Associated Urinary Tract Inf.. | 1 0.62 19.14 Central Line Associated Bloodstream I.. | 2 1.23 20.37 Central Line Associated Bloodstream I.. | 1 0.62 20.99 Central Line Associated Bloodstream I.. | 1 0.62 21.60 Central Venous Catheter-Related Blood.. | 1 0.62 22.22 Chronic Obstructive Pulmonary Disease.. | 1 0.62 22.84 Chronic Obstructive Pulmonary Disease.. | 2 1.23 24.07 Clostridium Difficile (C.Diff) | 1 0.62 24.69 Colonoscopy Interval for Patients wit.. | 1 0.62 25.31 Combination Chemotherapy Breast Cancer | 1 0.62 25.93 Combined SSI | 2 1.23 27.16 Complication Rate Following Elective .. | 1 0.62 27.78 Complication Rate Following Elective .. | 1 0.62 28.40 Complication/patient safety for selec.. | 3 1.85 30.25 Death among surgical inpatients with .. | 1 0.62 30.86 Discharged on Antithrombotic Therapy | 1 0.62 31.48 Discharged on Statin Medication | 1 0.62 32.10 Does your facility have the ability t.. | 1 0.62 32.72 Does/did your facility have the abili.. | 1 0.62 33.33 Domain_1_Score | 1 0.62 33.95 Domain_2_Score | 1 0.62 34.57 Elective Delivery | 1 0.62 35.19 Emergency Department Volume | 1 0.62 35.80 Evaluation of LVS Function | 1 0.62 36.42 Fibrinolytic Therapy Received Within .. | 1 0.62 37.04 Fibrinolytic Therapy Received Within .. | 2 1.23 38.27 Fibrinolytic Therapy Received within .. | 1 0.62 38.89 Follow-up after Hospitalization for M.. | 1 0.62 39.51 Follow-up after Hospitalization for M.. | 1 0.62 40.12 HCAHPS Linear Score for each measure | 1 0.62 40.74 HCAHPS Measures | 2 1.23 41.98 HCAHPS Summary Star Rating | 1 0.62 42.59 Head CT or MRI Scan Results for Acute.. | 1 0.62 43.21 Healthcare Personnel Influenza Vaccin.. | 1 0.62 43.83 Heart Failure (HF) 30-Day Readmissio.. | 1 0.62 44.44 Heart Failure (HF) 30-Day Mortality R.. | 3 1.85 46.30 Heart Failure (HF) 30-Day Readmissions | 1 0.62 46.91 Home Management Plan of Care (HMPC) D.. | 1 0.62 47.53 Hospital Acquired Potentially-Prevent.. | 1 0.62 48.15 Hospital Outpatient Volume Data on Se.. | 1 0.62 48.77 Hours of physical-restraint use | 1 0.62 49.38 Hours of seclusion | 1 0.62 50.00 Iatrogenic pneumothorax, adult Rate | 1 0.62 50.62 Influenza Immunization | 3 1.85 52.47 Initial Antibiotic Selection for CAP .. | 3 1.85 54.32 Intensive Care Unit Venous Thromboemb.. | 1 0.62 54.94 Left without being seen | 1 0.62 55.56 MRI Lumbar Spine for Low Back Pain | 1 0.62 56.17 MRSA Bacteremia | 1 0.62 56.79 Mammography Follow-up Rates | 1 0.62 57.41 Median Time from ED Arrival to ED Dep.. | 1 0.62 58.02 Median Time from ED Arrival to ED Dep.. | 1 0.62 58.64 Median Time from ED Arrival to Provid.. | 1 0.62 59.26 Median Time to ECG | 1 0.62 59.88 Median Time to Fibrinolysis | 1 0.62 60.49 Median Time to Pain Management for Lo.. | 1 0.62 61.11 Median Time to Transfer to Another Fa.. | 1 0.62 61.73 Participation in a Systematic Clinica.. | 1 0.62 62.35 Participation in a Systematic Clinica.. | 1 0.62 62.96 Participation in a Systematic Databas.. | 1 0.62 63.58 Patient satisfaction survey results | 1 0.62 64.20 Patients discharged on multiple antip.. | 1 0.62 64.81 Patients discharged on multiple antip.. | 1 0.62 65.43 Perioperative Pulmonary Embolism (PE).. | 1 0.62 66.05 Pneumonia 30-Day Mortality Rate | 3 1.85 67.90 Pneumonia 30-Day Readmission Rate | 1 0.62 68.52 Pneumonia 30-Day Readmissions | 1 0.62 69.14 Post-discharge continuing care plan c.. | 1 0.62 69.75 Post-discharge continuing care plan t.. | 1 0.62 70.37 Postoperative Hip Fracture Rate | 1 0.62 70.99 Postoperative Sepsis Rate | 1 0.62 71.60 Postoperative wound dehiscence Rate | 1 0.62 72.22 Pressure Ulcer Rate | 1 0.62 72.84 Primary PCI Received Within 90 Minute.. | 1 0.62 73.46 Prophylactic Antibiotic Received With.. | 1 0.62 74.07 Prophylactic Antibiotic Selection for.. | 3 1.85 75.93 Prophylactic Antibiotics Discontinued.. | 3 1.85 77.78 Risk-Standardized Payment Associated .. | 1 0.62 78.40 Risk-Standardized Payment Associated .. | 1 0.62 79.01 Risk-Standardized Payment Associated .. | 1 0.62 79.63 SSI - Abdominal Hysterectomy | 3 1.85 81.48 SSI - Colon Surgery | 3 1.85 83.33 SSI_Score | 1 0.62 83.95 Safe Surgery Checklist Use | 2 1.23 85.19 Simultaneous use of brain Computed To.. | 1 0.62 85.80 Spending per Hospital Patient with Me.. | 3 1.85 87.65 Stroke (STK) 30-Day Readmission Rate | 1 0.62 88.27 Stroke Education | 1 0.62 88.89 Surgery Patients Who Received Appropr.. | 3 1.85 90.74 Surgery Patients on Beta-Blocker Ther.. | 3 1.85 92.59 Thorax CT - Use of Contrast Material | 1 0.62 93.21 Thrombolytic Therapy | 1 0.62 93.83 Total_HAC_Score | 1 0.62 94.44 Urinary Catheter Removed on Postoper.. | 3 1.85 96.30 Use of an Electronic Health Record | 1 0.62 96.91 Venous Thromboembolism (VTE) Prophyla.. | 1 0.62 97.53 Venous Thromboembolism Patients Recei.. | 1 0.62 98.15 Venous Thromboembolism Patients with .. | 1 0.62 98.77 Venous Thromboembolism Prophylaxis | 1 0.62 99.38 Venous Thromboembolism Warfarin Thera.. | 1 0.62 100.00 ----------------------------------------+----------------------------------- Total | 162 100.00 by Jean Roth , jroth@nber.org , 15 Nov 2016